MannKind Corp (NASDAQ:MNKD)

DNA

Short Sellers Get More Selective on Big Biotech

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
nasdaq-logo

The 6 Most Heavily Shorted Nasdaq Stocks in June

Between the May 15 and May 29 settlement dates, Sirius XM was dethroned as the most heavily shorted stock traded on the Nasdaq. A surge in short interest pushed Frontier ...
Read Full Story »
Sears_Greenville

5 Stocks a Raging Rally Could Not Save

The markets were in a frenzy Wednesday with the S&P 500, Nasdaq and Dow Jones Industrial Average all rising over 1%. However, there were a few companies holding back the ...
Read Full Story »
Biotechnology word cloud

Short Sellers Lose Some Conviction Against Big Biotech

The short interest data are out for the May 29 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
NASDAQ_stock_market

The 6 Most Shorted Nasdaq Stocks in May

Between the May 15 and May 29 settlement dates, biotech stock MannKind continued its climb up the ranks of the most heavily shorted stocks traded on the Nasdaq. It threatens ...
Read Full Story »
buy sell

Why MannKind Could Be an Endless Tug-of-War Stock

MannKind Corp. (NASDAQ: MNKD) is still one of the biggest battleground stocks out there in the realm of biotech and emerging pharma. After getting U.S. Food and Drug Administration (FDA) ...
Read Full Story »
153576724

Events and Presentations Shake Out MannKind Short Sellers

MannKind Corp. (NASDAQ: MNKD) remains one of the most controversial stocks in the realm of biotech and pharmaceuticals. After finally getting U.S. Food and Drug Administration (FDA) clearance for the ...
Read Full Story »
buy sell

5 Key Analyst Stock Picks With 50% to 100% Upside (or Even More)

With the stock market having finally decided to take a breather this past week, 24/7 Wall St. wanted to review some of the most aggressive analyst upgrades and rehashed ratings ...
Read Full Story »
Biotechnology word cloud

Short Sellers Get Even More Ambitious Against Biotech Leaders

The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
nasdaq-logo

The 5 Most Shorted Nasdaq Stocks in May

The five most heavily shorted stocks traded on the Nasdaq all saw increases in short interest between the April 30 and May 15 settlement dates. That was most apparent in ...
Read Full Story »
investing

Has MannKind Stock Finally Bottomed Out?

MannKind Corp. (NASDAQ: MNKD) is just about as controversial of a company as you will find today when it comes to biotech and pharma. Its recently launched Afrezza has had ...
Read Full Story »
biotech

Short Sellers Start to Get Nervous on Biotech

The short interest data are out for the April 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
nasdaq-logo

The 5 Most Shorted Nasdaq Stocks in April

Among the most heavily shorted stocks traded on the Nasdaq, short sellers seemed to shift their focus from semiconductor giant Intel to smaller rival AMD between the April 15 and ...
Read Full Story »
down market

The 52-Week Low Club for Monday

May 11, 2015: Here are four stocks among the 41 equities making new 52-week lows today. Xerox Corp. (NYSE: XRX) dropped about 1.7% on Monday to post a new 52-week ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AOL, Cisco, Etsy, GoDaddy, MannKind, Virtu, Caterpillar, Nokia and More

Stocks were up very slightly Monday morning, on the heels of a rate cut in China and after a strong week before. While stocks are close top all-time highs, the ...
Read Full Story »